Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lee Zou

Showing results (131-140 of 159) with videos related to

Pageof 16
Sort By:
Cell|April 8, 2010
A chromatin-mediated reversible drug-tolerant state in cancer cell subpopulationsSreenath V Sharma, Diana Y Lee, Bihua Li, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|February 13, 2013
Detection of impaired homologous recombination repair in NSCLC cells and tissuesMoritz Birkelbach, Natalie Ferraiolo, Liliana Gheorghiu, et al.
Science (New York, N.Y.)|May 25, 2023
US "China initiatives" promote racial biasShan-Lu Liu, Lishan Su, Kunxin Luo, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 25, 2024
A Translational Study of the ATR Inhibitor Berzosertib as Monotherapy in Four Molecularly Defined Cohorts of Advanced Solid TumorsGregory M Cote, Bose S Kochupurakkal, Khanh Do, et al.
The Journal of Clinical Investigation|January 22, 2026
ATR Safeguards Epithelial-to-Mesenchymal Transition by Countering R-loops and Enabling Transcription ReprogrammingParasvi S Patel, Jacob P Matson, Xiaojuan Ran, et al.
Science Advances|May 13, 2022
Translesion DNA synthesis mediates acquired resistance to olaparib plus temozolomide in small cell lung cancerMarcello Stanzione, Jun Zhong, Edmond Wong, et al.
Science (New York, N.Y.)|March 23, 2019
Racial profiling harms scienceShan Lu, Zhe Han, Mien-Chie Hung, et al.
Genes & Development|March 1, 2017
ATR inhibition disrupts rewired homologous recombination and fork protection pathways in PARP inhibitor-resistant BRCA-deficient cancer cellsStephanie A Yazinski, Valentine Comaills, Rémi Buisson, et al.
Biorxiv : the Preprint Server for Biology|October 17, 2024
Inhibition of Androgen Receptor Exposes Replication Stress Vulnerability in Prostate CancerCarly S Williams, Xin Li, Hongjun Jang, et al.
Nature Communications|January 17, 2023
CRISPR screens reveal genetic determinants of PARP inhibitor sensitivity and resistance in prostate cancerTakuya Tsujino, Tomoaki Takai, Kunihiko Hinohara, et al.
Pageof 16

Showing results (131-140 of 159) with videos related to

Sort By:
Pageof 16
Cell|April 8, 2010
A chromatin-mediated reversible drug-tolerant state in cancer cell subpopulationsSreenath V Sharma, Diana Y Lee, Bihua Li, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|February 13, 2013
Detection of impaired homologous recombination repair in NSCLC cells and tissuesMoritz Birkelbach, Natalie Ferraiolo, Liliana Gheorghiu, et al.
Science (New York, N.Y.)|May 25, 2023
US "China initiatives" promote racial biasShan-Lu Liu, Lishan Su, Kunxin Luo, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 25, 2024
A Translational Study of the ATR Inhibitor Berzosertib as Monotherapy in Four Molecularly Defined Cohorts of Advanced Solid TumorsGregory M Cote, Bose S Kochupurakkal, Khanh Do, et al.
The Journal of Clinical Investigation|January 22, 2026
ATR Safeguards Epithelial-to-Mesenchymal Transition by Countering R-loops and Enabling Transcription ReprogrammingParasvi S Patel, Jacob P Matson, Xiaojuan Ran, et al.
Science Advances|May 13, 2022
Translesion DNA synthesis mediates acquired resistance to olaparib plus temozolomide in small cell lung cancerMarcello Stanzione, Jun Zhong, Edmond Wong, et al.
Science (New York, N.Y.)|March 23, 2019
Racial profiling harms scienceShan Lu, Zhe Han, Mien-Chie Hung, et al.
Genes & Development|March 1, 2017
ATR inhibition disrupts rewired homologous recombination and fork protection pathways in PARP inhibitor-resistant BRCA-deficient cancer cellsStephanie A Yazinski, Valentine Comaills, Rémi Buisson, et al.
Biorxiv : the Preprint Server for Biology|October 17, 2024
Inhibition of Androgen Receptor Exposes Replication Stress Vulnerability in Prostate CancerCarly S Williams, Xin Li, Hongjun Jang, et al.
Nature Communications|January 17, 2023
CRISPR screens reveal genetic determinants of PARP inhibitor sensitivity and resistance in prostate cancerTakuya Tsujino, Tomoaki Takai, Kunihiko Hinohara, et al.
Pageof 16